[Long-term use of 200 mg Dogmatil. Apropos of 13 cases].
A retrospective study of the follow up in 13 patients under maintenance Dogmatil 200 mg treatment (1 to 12 years) establishes the drug's effectiveness and tolerance. The best results were obtained in plain schizophrenia, borderline states and severe neuroses.
D000328:Adult; D000639:Amitriptyline / Q000008:administration & dosage; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001714:Bipolar Disorder / Q000188:drug therapy; D001883:Borderline Personality Disorder / Q000188:drug therapy; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy; D010259:Paranoid Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy; D013469:Sulpiride / Q000008:administration & dosage*; D013997:Time Factors; D014272:Trifluperidol / Q000008:administration & dosage; D014299:Trimipramine / Q000008:administration & dosage
D014150:Antipsychotic Agents; D000639:Amitriptyline; D014299:Trimipramine; D013469:Sulpiride; D006220:Haloperidol; D014272:Trifluperidol
Utilisation au long cours du Dogmatil 200 mg. A propos de treize observations.